10x Genomics, Inc. (TXG)

10x Genomics Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for 10x Genomics stock have an average target of 19.79, with a low estimate of 12 and a high estimate of 32. The average target predicts an increase of 163.52% from the current stock price of 7.51.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$19.79	$18	$32
Change	+59.79%	+163.52%	+139.68%	+326.10%

Analyst Ratings

The average analyst rating for 10x Genomics stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	4	4	4	4	4
Buy	4	4	4	3	3	3
Hold	7	7	7	8	8	8
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	16	16	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luke Sergott Barclays	Barclays	Buy Maintains $15 → $12	Buy	Maintains	$15 → $12	+59.79%	Apr 10, 2025
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $20 → $15	Strong Buy	Maintains	$20 → $15	+99.73%	Mar 4, 2025
Tejas Savant Morgan Stanley	Morgan Stanley	Buy Maintains $28 → $26	Buy	Maintains	$28 → $26	+246.21%	Feb 14, 2025
Luke Sergott Barclays	Barclays	Buy Maintains $18 → $15	Buy	Maintains	$18 → $15	+99.73%	Feb 14, 2025
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $20 → $18	Strong Buy	Maintains	$20 → $18	+139.68%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

615.40M

Increased by 0.76%

from 610.79M

Revenue Next Year

672.49M

Increased by 9.28%

from 615.40M

EPS This Year

-1.51

from -1.52

EPS Next Year

-1.16

from -1.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	298.85M	490.49M	516.41M	618.73M	610.79M	615.40M	672.49M	735.56M
Revenue Growth	21.54%	64.13%	5.28%	19.81%	-1.28%	0.76%	9.28%	9.38%
EPS	-5.37	-0.53	-1.46	-2.18	-1.52	-1.51	-1.16	-0.83
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	20	20	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	649.9M	721.7M	810.5M
Avg	615.4M	672.5M	735.6M
Low	585.1M	627.6M	668.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	6.4%	17.3%	20.5%
Avg	0.8%	9.3%	9.4%
Low	-4.2%	2.0%	-0.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.20	-0.17	-0.30
Avg	-1.51	-1.16	-0.83
Low	-1.81	-1.71	-1.35

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.